HIGHNOON LABORATORIES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 695.43 PKR | +0.17% |
|
-0.49% | +37.83% |
| Aug. 29 | Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
| Jul. 22 | Highnoon Laboratories Limited Announces Executive Changes | CI |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Pharmaceuticals | 9.05B | 10.7B | 13B | 15.82B | 19.77B | |||||
Total Assets | 4.73B | 6.64B | 8.28B | 10.96B | 14.74B | |||||
Interest Expense | -29.79M | -25.73M | -27.44M | -57.07M | -149M | |||||
Income Tax Expense | 368M | 525M | 579M | 972M | 912M | |||||
CAPEX | -265M | -367M | -299M | -851M | -788M | |||||
EBT | 1.37B | 2B | 2.44B | 3.45B | 3.36B | |||||
Gross Profit | 4.23B | 5.24B | 6.52B | 8.19B | 9.4B | |||||
D&A | 145M | 156M | 197M | 216M | 266M | |||||
Operating Income | 1.32B | 1.93B | 2.31B | 3.2B | 3.32B | |||||
Net Income | 1B | 1.47B | 1.86B | 2.47B | 2.45B |
Geographical Revenue Distribution History
| Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
Pakistan | 8.55B | 10.14B | 12.43B | 14.93B | 18.57B | |||||
Afghanistan | - | 343M | 296M | 589M | 750M | |||||
United Arab Emirates | - | 83.91M | 106M | 103M | 143M | |||||
France | - | 68.12M | 68.12M | 49.71M | 81.53M | |||||
Dubai | - | - | - | 19.89M | 78.48M | |||||
Iraq | - | - | 14.37M | 61.12M | 45.08M | |||||
Tanzania | - | 7.95M | 3.91M | 21.09M | 39.03M | |||||
Sudan | - | - | - | - | 22.1M | |||||
Kenya | - | 26.19M | 64.63M | 15.37M | 20.53M | |||||
Cambodia | - | 18.75M | 6.87M | 18.25M | 15.84M | |||||
Others | - | 7.64M | 5.71M | 11.44M | 4.64M | |||||
Unallocated | 104M | - | - | - | - | |||||
Unallocated Sales Tax | - | - | - | - | - | |||||
Unallocated Discount | - | - | - | - | - | |||||
Unallocated Toll Manufacturing | - | - | - | - | - | |||||
Corporate | - | - | - | - | - | |||||
Export | 394M | - | - | - | - |
- Stock Market
- Equities
- HINOON Stock
- Financials Highnoon Laboratories Limited
- Business Segments